Annual Drug Patent Expirations for REVLIMID Revlimid is a drug marketed by Celgene and is included in one NDA. It is available from one supplier. There are fifteen patents protecting…
The post New patent expiration for Celgene drug REVLIMID appeared first on DrugPatentWatch - Make Better Decisions.